Corentec코렌텍
104540 · KOSDAQ · ₩104540 · 코렌텍
- Market cap
- ₩70B
- Enterprise value
- ₩74B
- P/E
- 9.1×
- P/B
- 0.8×
- Dividend yield
- 0.0%
- ROE
- 9.2%
- Net margin
- 7.3%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−29.7% from the high
₩3,385Today: ₩5,080 – ₩5,250₩7,440
Returns
- 1W+0.2%
- 1M+30.8%
- 3M+31.7%
- 6M−12.0%
- YTD−21.9%
- 1Y−0.9%
- Volume today
- 33,865
- 0.1× the 20-day average
- Traded today
- ₩176M
- Listed shares
- 13,407,410
- EPS (12 months)
- ₩573
- Earnings yield 11.0%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 26 of 100 (50 is a normal day for this stock).
- MomentumStrong31.7% over the last month; the price is above its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Corentec stock overview
Corentec (코렌텍, KRX: 104540) is listed on KOSDAQ, in the Medical & precision devices sector. The company develops, manufactures and sells orthopedic joint implants, the first Korean company specialized in artificial joints, founded in 2000. Its shares closed at ₩5,230 on Oct 27, 2026, up 1.95% on the day, giving it a market value of ₩70B.
Key facts
- Market cap
- ₩70B
- Sector
- Medical & precision devices
- Latest price change
- +1.95%
- As of
- Oct 27, 2026
- Main business
- The company develops, manufactures and sells orthopedic joint implants, the first Korean company specialized in artificial joints, founded in 2000.
Quick answers about Corentec
- What does Corentec do?
- The company develops, manufactures and sells orthopedic joint implants, the first Korean company specialized in artificial joints, founded in 2000. Its main products are artificial hip and knee joints, which together account for most of its sales, along with spinal fixation devices and shoulder implants. Its subsidiary Sun Healthcare International provides corporate health checkups in Korea and operates an ambulatory surgery center in the United States, while another subsidiary handles US sales of artificial joints.
- What is the market cap of Corentec?
- The market capitalisation of Corentec was ₩70B at the close on Oct 27, 2026.
- Who are the largest shareholders of Corentec?
- According to the latest official filings, the largest reported holders are Seon Du-hun (21.15%, as of Jun 4, 2026); Hantu Hanwha Digital Healthcare No. 1 Private Equity Fund (5.49%, as of Jan 6, 2026); Sun Kyung-hoon (3.32%, as of Nov 20, 2025).
- When is the next earnings report from Corentec?
- Korean companies rarely announce results dates in advance. Based on when Corentec filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Company profile
The company develops, manufactures and sells orthopedic joint implants, the first Korean company specialized in artificial joints, founded in 2000. Its main products are artificial hip and knee joints, which together account for most of its sales, along with spinal fixation devices and shoulder implants. Its subsidiary Sun Healthcare International provides corporate health checkups in Korea and operates an ambulatory surgery center in the United States, while another subsidiary handles US sales of artificial joints. The company sells its products in Korea and overseas through dealers, consignment agents and sales agents.
Written by AI from the company's latest annual report.
- Korean name
- 코렌텍
- CEO
- 현동욱
- Founded
- May 2000
- Listed
- Mar 2013
- Listed shares
- 13,407,410
- Fiscal year ends
- Month 12
- Website
- www.corentec.com
Similar companies
- TSE131290 · ₩2.9T₩260,000+7.88%
- Kctech281820 · ₩1.8T₩91,900+6.37%
- Classys214150 · ₩1.7T₩26,500−2.57%
- Park Systems140860 · ₩1.6T₩225,500+1.12%
- Curiox Biosystems445680 · ₩1.1T₩62,300+6.13%
- DI003160 · ₩1.1T₩37,800+4.71%
- Seers458870 · ₩1T₩26,300−5.57%
- LivsMed491000 · ₩937B₩37,100+1.50%
Recent filings
See all- Half-year report (Jun 2026)Aug 14, 2026
- Preliminary earnings (consolidated)Jul 24, 2026
- Insider shareholding reportJun 11, 2026
- Insider shareholding reportJun 5, 2026
- Insider shareholding reportJun 5, 2026
Titles in Korean until English translations are added.
Also known as: Corentec / 코렌텍 / 104540 / KRX:104540
Source: KRX statistical information